Low grade prostate cancer may be treated with mild treatment

In the Journal of American Medical Association, a recent study had shown that low-grade prostate cancer has a very less risk of developing in next 20 years.

Scientists have treated men in the age of to 74 years who were diagnosed with clinically localized prostate cancer conservatively. They have used either observation or immediate or delayed androgen withdrawal therapy. The patients were observed for a mean period of 24 years.

The results of the study had shown that patients with low-grade prostate cancer had very less of cancer progressing in 20 years under observation or treatment by androgen withdrawal therapy alone. The risk of death from low-grade prostate cancer seems to be 0.6% only for each year.

A low-grade prostate cancer is the one, which can be given a rating of 2 to 4 in the Gleason scale. In the poorly differentiated disease which has a Gleason score of 7 to 10, the risk of death increases to about 12.1% for people diagnosed with prostate cancer and dying within 10 years of dying.

The researchers are of the opinion that patients diagnosed with low-grade prostate cancer, thus, should not be treated aggressively medically as the disease can be controlled otherwise. , low-grade prostate cancer, Gleason score, less risk of developing, androgen withdrawal therapy, poorly differentiated disease